Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 12:12 AM
NCT ID:
NCT06567158
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent (ICF) (both children/adolescents and parents)
* ≥7 and ≤17 years old at moment of ICF signature
* ≥6 months type 1 diabetes diagnosis at moment of ICF signature
* ≥3 months use of the hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
* Ability to understand, read, write and speak Dutch, French or English at moment of ICF signature
Exclusion Criteria:
* \<7 or \>17 years old at moment of ICF signature
* \<6 months type 1 diabetes diagnosis at moment of ICF signature
* \<3 months use of the advanced hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
* Any other insulin therapy than advanced hybrid closed-loop system Medtronic MiniMedTM 780G , Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
* Failure to understand, read, write or speak Dutch, French or English at moment of ICF signature
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
17 Years
Study:
NCT06567158
Study Brief:
Protocol Section:
NCT06567158